A website to provide support for people who have or have had any type of cancer, for their caregivers and for their family members.
Page 9 of 9 FirstFirst ... 789
Results 81 to 85 of 85

Thread: Assessment & suggestions regarding my advanced prostate cancer

  1. #81
    Nice going CC33...GREAT NEWS!!
    DOB:Feb 1958
    PSA: 9/15: 5.9
    DRE: Negative
    Biopsy: 10/1/15. Second Opinion University of Chicago. +9 of 12 cores. G6: 5 cores, G7 ( 4+3) 4 cores
    10/12/15: -CT scan/BS
    Clinical Staging: 10/28/15 T2c
    ( RALP) UC 12/29/15

    Final Pathology Report; Jan. 6 2016

    -15 lymph nodes
    G9 ( 4+5)
    +EPE
    +LVI
    +Right SV -Left SV and vasa deferentia,
    PI present
    PM
    pT3bNO
    uPSA 2/9/16 0.05
    uPSA 3/23/16 0.11
    Casodex 4/1/16-8/5/16
    Lupron 4/15/16-5/15/18
    SRT 6/14/16...8/5/16 38Tx
    uPSA 8/10/16---2/14/19 <0.05
    Feb. 2017 Loyola Chicago
    11/15/2018 AUS 800 Implanted
    12/18/18...T Levels...Free T 42.8...Total T...262

  2. #82
    Experienced User
    Join Date
    Jul 2016
    Posts
    72
    PSA test on 20/04/19 : 0,003 ng/ml
    July 2015 biopsy at age 62: Prostate cancer Gleason 8 & 9, bone scan clear, MRI clear
    August 2015: Proactive hormone therapy prior the surgery (neoadjuvant therapy)
    September 2015: Da vinci prostatectomy and extended lymphadenectomy 40% prostate cancer, 2/4 positive margins, 1/2 involved seminal vehicle, 2/34 positive nodes of 0,0008 cm total size of node cancer involvement .pT3bN1R1M0
    November 2015: IMRT radiotherapy of 35 rounds with high voltage initiated & Hormone therapy + anti - androgens (complete hormone blockade) every 3 months scheduled until 2/11/2017

    PSA 30/9/15: 0,020 ng/ml (before radiotherapy)
    PSA 30/11/15 until 20/04/19 : 0,003 ng/ml

  3. #83
    Hi C33

    Congrats & Happy Easter!!!

    Once again, it's not possible to have a better result!

    Keep them coming.

    MF
    Last edited by Michael F; 04-20-2019 at 08:26 PM.

  4. #84
    Top User garyi's Avatar
    Join Date
    Apr 2017
    Posts
    1,222
    Quote Originally Posted by Consultant33 View Post
    PSA test on 20/04/19 : 0,003 ng/ml
    You can't get any lower than that!
    72...LUTS for the past 7 years
    TURP 2/16,
    G3+4 discovered
    3T MRI 5/16
    MRI fusion guided biopsy 6/16
    14 cores; four G 3+3, one G3+4,
    CIPRO antibiotic = C. Diff infection 7/16
    Cured with Vanco for 14 days
    Second 3T MRI 1/17
    Worsened bulging of posterior capsule
    Oncotype DX GPS 3/17, LFP risk 63%, Likelihood of Low
    Grade Disease 81%, Likelihood of Organ Confined 80%
    RALP 7/13/17 Dr. Gonzaglo @ Univ of Miami
    G3+4 Confirmed, Organ confined
    pT2 pNO pMn/a Grade Group 2
    PSA 0.32 to .54 over 3 months
    DCFPyl PET & ercMRI Scans - 11/17
    A one inch tumor still in prostate bed = failed surgery
    All met scans clear
    SRT, 2ADT, IMGT 70.2 Gys @1.8 per, completed 5/18
    Radiation Procitis, and Ulcerative Colitis flaired after 20 years
    PSA <.006 9/18, .054 11/18, .070 12/18, .067 2/19, .078 5/19, .074 7/19
    We'll see....what is not known dwarfs what is thought to be fact

  5. #85
    Senior User
    Join Date
    Feb 2019
    Posts
    128
    Outstanding ... best news I am loving to hear !
    Age DX 63 dob 1955
    8/11/16 CT scan (blood/sand in urine). Prostate norm w/cent calcification.
    11/6/18 GP freq urine/retro ejact. PSA 7.1 (RX Proscar/Flomax)
    12/18 PSA 4.1 14.8% Free Proscar? MRI Lesion 1.6cm. Lymph nodes sim to 2016 CT, prostate norm size. Stage 3. PIRADS 4
    1/19 Biopsy 2/5/19 DX
    2/19 Bone/CT scans: No evid met chest/abd/pelvis
    3/2019 RALP Cath out/post-op path rpt week later:
    G9 (4+5) (65-70% + 15-20%)
    Dominant tumor: 4.3 cm apex to base, bilat.
    LNI+ (4 of 12 on R, largest 4mm, 1 of 8 on L, 9 mm)
    EPE+ (right lat., post. and L lat. aspects apex to base and at ant. mid aspect)
    Intaraductal component+, BNI-, SVI+, LVI+
    SM+ (carcinoma unifocally extends to ant. mid margin area of EPE (2mm)
    Prostate fat: neg. pT3b pN1
    5/2019 Began oral Casodex. uPSA 0.11 2 wks later Lupron inject ( 3mo). 8 wks of RT begin Aug.
    6/19 uPSA .02

 

Similar Threads

  1. Johns Hopkins Revises Their Risk Assessment Criteria
    By ASAdvocate in forum Prostate Cancer Forum
    Replies: 0
    Last Post: 01-27-2015, 04:27 PM
  2. ASCO reworked their assessment from 2004
    By gdpawel in forum Cancer News
    Replies: 11
    Last Post: 01-06-2013, 01:30 AM
  3. Any Suggestions Here Regarding to Insurance?
    By di_mack in forum Financial issues
    Replies: 2
    Last Post: 05-10-2006, 02:13 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •